Rossari Biotech Board Meeting on July 18, 2026 for Unaudited Financial Results

Rossari Biotech Ltd has announced that its Board of Directors will convene on July 18, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026, on both standalone and consolidated bases. Concurrently, the company has confirmed that the trading window for its securities will remain closed for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the announcement of these financial results. The company's website will host this intimation.